10.6084/m9.figshare.c.3617414_D1.v1 Birgit EngesĂŚter Birgit EngesĂŚter Bianca van Diermen Hidle Bianca van Diermen Hidle Mona Hansen Mona Hansen Pia Moltu Pia Moltu Kjersti Staby Kjersti Staby Siri Borchgrevink-Persen Siri Borchgrevink-Persen Olav Vintermyr Olav Vintermyr Stefan LĂśnnberg Stefan LĂśnnberg Mari NygĂĽrd Mari NygĂĽrd Emiel Janssen Emiel Janssen Philip Castle Philip Castle Irene Christiansen Irene Christiansen Additional file 1: Table S1. of Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study Springer Nature 2016 Human papillomavirus HPV Cervical cancer screening HPV primary screening HPV testing Quality assurance Cobas 4800 HPV Test Inter-laboratory reproducibility 2016-11-24 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Quality_assurance_of_human_papillomavirus_HPV_testing_in_the_implementation_of_HPV_primary_screening_in_Norway_an_inter-laboratory_reproducibility_study/4382534 Ct-values for HPV and beta-globin detection in samples with discordant results. The Ct-values of the discordant samples were generally above 38.4 (with two exceptions), and hence close to the clinical Ct cut-off values. The Ct-values of beta-globin were for all samples between 25.5 and 28, indicating sufficient quality of the input DNA. (DOCX 18 kb)